| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6872
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate |
2012-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2015-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-103460042-B |
| titleOfInvention |
Use of GLU-tubulin as a biomarker of drug response to furazanbenzimidazoles |
| abstract |
Use of GLU-tubulin as a biomarker for predicting the response to a compound, preferably the resistance of a disease, such as cancer, to said compound in an individual, wherein said compound is of general formula (I) Furazanobenzimidazole compounds. |
| priorityDate |
2011-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |